Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
June 14, 2022
Monkeypox has been around for decades, but it has been low priority for global and public health, despite a notable reemergence of the disease in West and Central Africa in 2017. Now, as the virus reaches 35 countries outside the West and Central African regions, the disease’s current dynamics are s...
Blog Post
June 13, 2022
This week, the House Foreign Affairs Committee turns its attention to the resourcing needs of the Millennium Challenge Corporation and US International Development Finance Corporation—two agencies that fill distinct functions within the US development architecture. We’ll be listening for lawmakers’ ...
Blog Post
June 10, 2022
In June 2021, Dr. Tedros Ghebreyesus, offered a challenge to the world: “To truly end the pandemic, our goal must be to vaccinate at least 70 percent of the world’s population by the time you meet again in Germany next year.” However, as we approach this year’s G7 summit, the 70 percent target has b...
Blog Post
May 26, 2022
Yesterday at the annual World Health Assembly in Geneva, member states passed a resolution tabled by the Argentina, Peru, and the UK that aims to strengthen clinical trials to improve public health. As COVID-19 has made abundantly clear, the evidence generated by high-quality clinical trials is esse...
Blog Post
May 04, 2022
The US government wants to fund as many new clean energy projects in Africa as possible, but the pool of bankable utility-scale generation projects is running dry. In 2021, the DFC approved none. To accelerate Africa’s energy transition and scale its clean energy markets, the US needs to focus far m...
BRIEFS
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.
Blog Post
April 28, 2022
In the past two years, we have all learned that the end of a COVID-19 wave is the end of a chapter, not the end of the story. Ongoing COVID transmission means the risk of new variants of pandemic potential is ever present and vaccination remains our best defence. The primary near-term challenges for...
BRIEFS
April 28, 2022
COVID-19 radically changed most people’s lives in 2020, including across Africa. In Ethiopia, the disruption started with school closing, and other restrictions soon followed. Despite these efforts to contain the virus, Ethiopia—like almost all countries—suffered significant health impacts. It has r...
WORKING PAPERS
April 21, 2022
Education is one of the most important public goods provided by modern governments. Yet governments worldwide seldom perform well in the sector. This raises the question: Why do governments preside over poor education quality? This paper answers this question with evidence from Tanzania.
WORKING PAPERS
April 20, 2022
In developing Asia there is potential for higher corrective taxes to help prevent many non-communicable diseases (NCDs) and contribute revenue. The productivity loss from death and disability from alcohol, tobacco and diets high in sugar-sweetened beverages in purchasing power parity dollars is PPP$...